Mai Trong Khoa, Nguyen Son Lam, Pham Cam Phuong, Nguyen Thuan Loi, Vo Thi Thuy Quynh, Pham Van Thai, Pham Van Tuyen, Vu Binh Thu, Vu Thi Thu Hien, Hoang Quoc Binh, Le Thi Bich Ngoc
{"title":"越南晚期和转移性肺鳞状细胞癌中EGFR突变发生率的测定","authors":"Mai Trong Khoa, Nguyen Son Lam, Pham Cam Phuong, Nguyen Thuan Loi, Vo Thi Thuy Quynh, Pham Van Thai, Pham Van Tuyen, Vu Binh Thu, Vu Thi Thu Hien, Hoang Quoc Binh, Le Thi Bich Ngoc","doi":"10.25073/2588-1132/vnumps.4401","DOIUrl":null,"url":null,"abstract":"Abstract: This paper aims to determine the rate of epidermal growth factor receptor (EGFR) gene mutations in advanced and metastatic squamous cell lung cancer in Vietnamese patients. EGFR mutation testing was performed on 559 formalin-fixed paraffin-embedded tissue samples from advanced and metastatic squamous cell lung cancer patients by real-time PCR. The results showed that EGFR mutations were found in 8.4%. Most of them were exon 19 deletions, approximately 51.1%. Multivariate analysis showed that EGFR mutations were more prevalent in gender (p<0.0001). In conclusion, EGFR mutation testing should be performed in patients with squamous cell lung cancer. \nKeywords: Lung squamous cell carcinoma, EGFR gene. \n \n ","PeriodicalId":23520,"journal":{"name":"VNU Journal of Science: Medical and Pharmaceutical Sciences","volume":"207 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Determination of EGFR Mutation Prevalence in Advanced and Metastatic Lung Squamous Cell Carcinoma in Vietnam\",\"authors\":\"Mai Trong Khoa, Nguyen Son Lam, Pham Cam Phuong, Nguyen Thuan Loi, Vo Thi Thuy Quynh, Pham Van Thai, Pham Van Tuyen, Vu Binh Thu, Vu Thi Thu Hien, Hoang Quoc Binh, Le Thi Bich Ngoc\",\"doi\":\"10.25073/2588-1132/vnumps.4401\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract: This paper aims to determine the rate of epidermal growth factor receptor (EGFR) gene mutations in advanced and metastatic squamous cell lung cancer in Vietnamese patients. EGFR mutation testing was performed on 559 formalin-fixed paraffin-embedded tissue samples from advanced and metastatic squamous cell lung cancer patients by real-time PCR. The results showed that EGFR mutations were found in 8.4%. Most of them were exon 19 deletions, approximately 51.1%. Multivariate analysis showed that EGFR mutations were more prevalent in gender (p<0.0001). In conclusion, EGFR mutation testing should be performed in patients with squamous cell lung cancer. \\nKeywords: Lung squamous cell carcinoma, EGFR gene. \\n \\n \",\"PeriodicalId\":23520,\"journal\":{\"name\":\"VNU Journal of Science: Medical and Pharmaceutical Sciences\",\"volume\":\"207 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"VNU Journal of Science: Medical and Pharmaceutical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25073/2588-1132/vnumps.4401\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"VNU Journal of Science: Medical and Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25073/2588-1132/vnumps.4401","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Determination of EGFR Mutation Prevalence in Advanced and Metastatic Lung Squamous Cell Carcinoma in Vietnam
Abstract: This paper aims to determine the rate of epidermal growth factor receptor (EGFR) gene mutations in advanced and metastatic squamous cell lung cancer in Vietnamese patients. EGFR mutation testing was performed on 559 formalin-fixed paraffin-embedded tissue samples from advanced and metastatic squamous cell lung cancer patients by real-time PCR. The results showed that EGFR mutations were found in 8.4%. Most of them were exon 19 deletions, approximately 51.1%. Multivariate analysis showed that EGFR mutations were more prevalent in gender (p<0.0001). In conclusion, EGFR mutation testing should be performed in patients with squamous cell lung cancer.
Keywords: Lung squamous cell carcinoma, EGFR gene.